Keratinocyte TMEM79 protects early life epidermal homeostasis and restrains STING-dependent skin inflammation
12 affiliations
- 1F. M. Kirby Neurobiology Center, Boston Children’s Hospital, Harvard Medical School , Boston, MA ,
- 2Division of Gastroenterology, Hepatology, and Nutrition, Boston Children’s Hospital , Boston, MA ,
- 3Harvard Graduate Program in Biological and Biomedical Sciences, Harvard Medical School , Boston, MA ,
- 4Yunnan Key Laboratory of Cell Metabolism and Diseases, Center for Life Sciences, School of Life Sciences, Yunnan University ,
- 5Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School , Boston, MA ,
- 6Program in Immunology, Harvard Medical School , Boston, MA ,
- 7Broad Institute of MIT and Harvard , Cambridge, MA ,
- 8Harvard Stem Cell Institute , Cambridge, MA ,
- 9Ragon Institute of MGH, MIT and Harvard , Cambridge, MA ,
- 10Division of Immunology, Boston Children’s Hospital, Harvard Medical School , Boston, MA ,
- 11Department of Immunology, Harvard Medical School , Boston, MA ,
- 12Gene Lay Institute of Immunology and Inflammation of Brigham and Women’s Hospital, MGH, and Harvard Medical School , Boston, MA ,
Abstract
Chronic inflammatory skin diseases are characterized by epithelial barrier dysfunction and immune dysregulation, yet the epithelial-intrinsic mechanisms that initiate inflammation remain poorly understood. TMEM79 is a dermatitis-associated transmembrane protein expressed in keratinocytes, but how its loss promotes skin disease remains unclear. Here, using keratinocyte-specific Tmem79 conditional knockout (cKO) mice and TMEM79-deficient human keratinocytes, we find that TMEM79 is required for proper epithelial differentiation and barrier formation, and that its loss induces keratinocyte stress and ferroptosis-associated lipid peroxidation. Longitudinal analysis of neonatal and early postnatal Tmem79-deficient skin revealed disrupted epidermal homeostasis and early type I IFN signaling preceding the later emergence of type 17 inflammation. Mechanistically, genetic ablation of Sting1, but not Mavs, ameliorated dermatitis and downstream type 17 inflammation, while IL-17A was required for subsequent epidermal hyperplasia. These findings establish STING-dependent signaling as an upstream driver of skin immune activation and pathology. Together, our findings link early-life epithelial stress to innate immune activation and suggest that targeting lipid peroxidation or STING signaling may help prevent inflammatory skin disease progression.
Related
- Heparinoid Cream Restores Epidermal Barrier Homeostasis and Attenuates Type 2 Inflammation in MC903-Induced Dermatitis
- Pathogen subversion of neuro-epidermal signaling impairs lysosomal function to disrupt collagen homeostasis in Caenorhabditis elegans
- TNF/TNFR1 axis restrains inflammation-suppressive myeloid subclusters to drive acute pancreatitis.
- LncRNA FLJ20021 Restrains Fibroblast Senescence and Matrix Remodeling in Pelvic Organ Prolapse by Promoting XRCC6‐Dependent ADI1 Transcription
- Amelioration of chronic inflammation, insulin resistance, and gut microbiota homeostasis by a combination of Bifidobacterium, Lactobacillus, Enterococcus, and Bacillus in obese type 2 diabetic mice
BibTeX
@article{ge2026keratinocyte,
title = {{Keratinocyte TMEM79 protects early life epidermal homeostasis and restrains STING-dependent skin inflammation}},
author = {Mengxu Ge and Danilo Predes and Andrew Kwong and Eunice To and Maorong Chen and Aakanksha Jain and Wenyi Wei and Jose Ordovas-Montanes and Manuel Leyva-Castillo and Isaac M Chiu and Xi He},
journal = {PNAS Nexus},
year = {2026},
month = oct,
doi = {10.1093/pnasnexus/pgag361},
url = {https://academic.oup.com/pnasnexus/advance-article/doi/10.1093/pnasnexus/pgag361/9003321},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Keratinocyte TMEM79 protects early life epidermal homeostasis and restrains STING-dependent skin inflammation
AU - Mengxu Ge
AU - Danilo Predes
AU - Andrew Kwong
AU - Eunice To
AU - Maorong Chen
AU - Aakanksha Jain
AU - Wenyi Wei
AU - Jose Ordovas-Montanes
AU - Manuel Leyva-Castillo
AU - Isaac M Chiu
AU - Xi He
PY - 2026
DA - 2026/10/28
JO - PNAS Nexus
DO - 10.1093/pnasnexus/pgag361
UR - https://academic.oup.com/pnasnexus/advance-article/doi/10.1093/pnasnexus/pgag361/9003321
AB - Chronic inflammatory skin diseases are characterized by epithelial barrier dysfunction and immune dysregulation, yet the epithelial-intrinsic mechanisms that initiate inflammation remain poorly understood. TMEM79 is a dermatitis-associated transmembrane protein expressed in keratinocytes, but how its loss promotes skin disease remains unclear. Here, using keratinocyte-specific Tmem79 conditional knockout (cKO) mice and TMEM79-deficient human keratinocytes, we find that TMEM79 is required for proper epithelial differentiation and barrier formation, and that its loss induces keratinocyte stress and ferroptosis-associated lipid peroxidation. Longitudinal analysis of neonatal and early postnatal Tmem79-deficient skin revealed disrupted epidermal homeostasis and early type I IFN signaling preceding the later emergence of type 17 inflammation. Mechanistically, genetic ablation of Sting1, but not Mavs, ameliorated dermatitis and downstream type 17 inflammation, while IL-17A was required for subsequent epidermal hyperplasia. These findings establish STING-dependent signaling as an upstream driver of skin immune activation and pathology. Together, our findings link early-life epithelial stress to innate immune activation and suggest that targeting lipid peroxidation or STING signaling may help prevent inflammatory skin disease progression.
SN - 2752-6542
ER -